TMC Life Sciences Berhad (KLSE:TMCLIFE)

Market Cap	827.39M
Revenue (ttm)	364.14M
Net Income (ttm)	5.08M
Shares Out	1.74B
EPS (ttm)	0.00
PE Ratio	162.78
Forward PE	n/a
Dividend	0.00 (0.39%)
Ex-Dividend Date	Dec 8, 2025

Volume	138,700
Average Volume	111,365
Open	0.4650
Previous Close	0.4650
Day's Range	0.4650 - 0.4750
52-Week Range	0.3650 - 0.5150
Beta	0.23
RSI	72.38
Earnings Date	Jan 23, 2026

About TMC Life Sciences Berhad

TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; a...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1994
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: TMCLIFE

Financial Performance

In 2025, TMC Life Sciences Berhad's revenue was 345.63 million, a decrease of -0.23% compared to the previous year's 346.42 million. Earnings were 3.61 million, a decrease of -91.13%.